Allarity Therapeutics (ALLR) Interest Expenses (2020 - 2026)
Allarity Therapeutics' (ALLR) quarterly Interest Expenses came in at $229000.0 in Q1 2026, up 301.75% YoY from $57000.0 in Q1 2025, and up 209.46% on a QoQ basis from $74000.0 in Q4 2025.
Allarity Therapeutics (ALLR) Interest Expenses (2020 - 2026) Analysis & Trends
Allarity Therapeutics (ALLR) has 7 years of Interest Expenses data on file, last reported at $229000.0 in Q1 2026.
- Quarterly Interest Expenses rose 301.75% year-over-year to $229000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $372000.0 (up 140.0% YoY) and the FY2025 annual result came in at $24.2 million, up 14.72% from the prior year.
- Interest Expenses rose to $229000.0 in Q1 2026, from $74000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $790000.0 in Q2 2022 to a low of -$378000.0 in Q4 2024.
- A 5-year average of $129058.8 and a median of $74000.0 in 2025 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses soared 745.83% — and 2024, when it sank 264.35%.
- Tracing ALLR's Interest Expenses over 5 years: stood at $203000.0 in 2022, then climbed by 13.3% to $230000.0 in 2023, then slumped by 264.35% to -$378000.0 in 2024, then soared by 119.58% to $74000.0 in 2025, then surged by 209.46% to $229000.0 in 2026.
- The last three Interest Expenses figures came in at $229000.0 (Q1 2026), $74000.0 (Q4 2025), and $57000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Allarity Therapeutics | 22.75 Mn | 22.75 Mn | - | 719,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 229,000.00 |
| Mar 31, 2026 | 229,000.00 |
| Dec 31, 2025 | 74,000.00 |
| Dec 31, 2025 | 74,000.00 |
| Sep 30, 2025 | 57,000.00 |
| Sep 30, 2025 | 57,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Mar 31, 2025 | 57,000.00 |
| Mar 31, 2025 | 57,000.00 |
| Dec 31, 2024 | -378,000.00 |
| Dec 31, 2024 | -378,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Jun 30, 2024 | 426,000.00 |
| Jun 30, 2024 | 426,000.00 |
| Mar 31, 2024 | 102,000.00 |
| Mar 31, 2024 | 102,000.00 |
| Dec 31, 2023 | 230,000.00 |
| Dec 31, 2023 | 230,000.00 |